Informazioni su Adaptive Biotechnologies Corporation - Common Stock Panoramica della società da Wikipedia

Wikidata ↗

ADPT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$24.88

Capitalizzazione di Mercato

$3.83B

P/E (TTM)

-63.8

EPS (TTM)

$-0.39

Ricavi (TTM)

$277M

Rendimento div.

—

ROE

-28.2%

D/E Debito/Patrimonio

0.6

Intervallo 52 sett.

$12 – $26

ADPT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $277M

2017-12-31 → 2025-12-31

EPS $-0.39

2020-12-31 → 2025-12-31

Flusso di cassa libero $-49M

2019-12-31 → 2025-12-31

Margini -21.5%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

P/E (TTM)

-63.8

91.9

P/S (TTM)

13.8

4.4

P/B

17.5

3.0

EV / EBITDA

-68.0

—

Price / FCF (Prezzo / FCF)

-78.2

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

Operating Margin (Margine Operativo)

-20.6%

—

Net Profit Margin (Margine di Profitto Netto)

-21.5%

-16.7%

ROA

-11.3%

-7.4%

ROE

-28.2%

-15.5%

ROIC

-16.3%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

0.6

0.1

Current Ratio (Rapporto corrente)

3.3

3.2

Quick Ratio

1.3

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

Revenue YoY (Ricavi YoY)

54.8%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

14.3%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

23.0%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-0.39

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

ADPT

Mediana dei peer

ADPT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 14 analisti

Acquisto forte 5 35,7%
Compra 7 50,0%
Mantieni 2 14,3%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

7 analisti · 2026-08-19

Mediana $25.00

Ora $24.88

Basso $21.00

Alto $28.00

Target mediano $25.00 +0,5%

Target medio $25.07 +0,8%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.09%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$-0.10	$-0.14	0.04%
31 Marzo 2026	$-0.12	$-0.16	0.04%
31 Dicembre 2025	$-0.09	$-0.18	0.09%
30 Settembre 2025	$0.06	$-0.15	0.21%
30 Giugno 2025	$-0.17	$-0.24	0.07%
31 Marzo 2025	$-0.20	$-0.30	0.10%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	—
TEM	—	-41.9	83.4%	-19.3%	-61.2%	—
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
TXG	$2.08B	-46.6	5.2%	-6.8%	-5.5%	69.0%
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ALMR	—	—	—	—	—	—
BLFS	—	-241.8	28.9%	—	—	—
FTRE	$1.61B	-1.6	1.0%	-36.2%	-171.1%	—
PSNL	$816M	-8.7	-17.7%	-116.7%	-36.0%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 15

Dati annuali Conto Economico per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue	$277M	$179M	$170M	$185M	$154M	$98M	$85M	$56M
Cost of Revenue	$71M	$72M	$76M	$58M	$49M	$23M	$22M	$20M
R&D Expense	$94M	$103M	$122M	$142M	$142M	$116M	$71M	$39M
SG&A Expense	$73M	$73M	$84M	$89M	$75M	$50M	$30M	$20M
Operating Expenses	$334M	$342M	$397M	$385M	$363M	$251M	$163M	$105M
Operating Income	$-57M	$-163M	$-227M	$-200M	$-209M	$-153M	$-78M	$-50M
Interest Expense	$12M	$12M	$14M	$4M	·	·	·	·
Pretax Income	$-59M	$-160M	$-225M	$-200M	$-207M	$-146M	$-69M	·
Income Tax	$0	$0	$0	·	·	·	$0	·
Net Income	$-59M	$-159M	$-225M	$-200M	$-207M	$-146M	$-69M	$-46M
EPS (Basic)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·
EPS (Diluted)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·
Shares (Basic)	151,721,939	147,101,648	144,383,294	142,515,917	140,354,915	131,216,468	·	·
Shares (Diluted)	151,721,939	147,101,648	144,383,294	142,515,917	140,354,915	131,216,468	·	·
EBITDA	$-57M	$-163M	$-227M	$-200M	$-209M	$-153M	$-78M	·

Stato Patrimoniale 27

Dati annuali Stato Patrimoniale per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Cash & Equivalents	$70M	$48M	$65M	$90M	$139M	$123M	$97M	$55M
Receivables	$50M	$42M	$38M	$40M	$17M	$10M	$13M	$5M
Inventory	$10M	$8M	$14M	$14M	$19M	$14M	$9M	$8M
Prepaid Expense	$13M	$11M	$11M	$9M	$13M	$15M	$14M	$3M
Current Assets	$300M	$284M	$410M	$562M	$403M	$727M	$613M	$181M
PP&E (Net)	$34M	$49M	$68M	$83M	$85M	$40M	$60M	$19M
PP&E (Gross)	$130M	$136M	$141M	$138M	$121M	$64M	$78M	$32M
Accum. Depreciation	$96M	$88M	$73M	$54M	$36M	$24M	$18M	$12M
Goodwill	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M
Intangibles	$2M	$3M	$5M	$7M	$9M	$10M	$12M	$14M
Other Non-current Assets	$1M	$2M	$4M	$2M	$875.0K	$598.0K	$784.0K	$186.0K
Total Assets	$513M	$539M	$661M	$857M	$923M	$1.12B	$912M	$333M
Accounts Payable	$6M	$7M	$8M	$8M	$3M	$3M	$4M	$2M
Accrued Liabilities	$8M	$8M	$9M	$12M	$9M	$13M	$4M	$3M
Current Liabilities	$90M	$98M	$88M	$110M	$114M	$105M	$78M	$23M
Capital Leases	$70M	$79M	$89M	$99M	$107M	$104M	·	·
Other Non-current Liabilities	$20.0K	$20.0K	·	·	·	·	$93.0K	·
Total Liabilities	$288M	$337M	$353M	$393M	$319M	$373M	$341M	$30M
Long-term Debt	$131M	$133M	·	·	·	·	·	·
Total Debt	$131M	$133M	$131M	·	·	·	·	·
Common Stock	$15.0K	$14.0K	$14.0K	$14.0K	$14.0K	$14.0K	$12.0K	$1.0K
Paid-in Capital	$1.58B	$1.51B	$1.45B	$1.39B	$1.32B	$1.25B	$936M	$38M
Retained Earnings	$-1.36B	$-1.30B	$-1.14B	$-919M	$-719M	$-512M	$-365M	$-296M
AOCI	$253.0K	$166.0K	$215.0K	$-4M	$-1M	$893.0K	$671.0K	$-107.0K
Stockholders' Equity	$219M	$203M	$308M	$464M	$604M	$743M	$571M	$-258M
Liabilities + Equity	$513M	$539M	$661M	$857M	$923M	$1.12B	$912M	$333M
Shares Outstanding	153,779,418	147,773,744	145,082,271	143,105,002	141,393,865	137,646,896	125,238,142	12,841,536

Flusso di cassa 13

Dati annuali Flusso di cassa per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
D&A	$16M	$17M	$20M	$21M	·	·	·	·
Stock-based Comp	$51M	$54M	$63M	$55M	$43M	$25M	$13M	$11M
Amort. of Intangibles	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Restructuring	·	$2M	·	$2M	·	·	·	·
Operating Cash Flow	$-46M	$-95M	$-156M	$-184M	$-193M	$-150M	$205M	$-32M
CapEx	$3M	$4M	$11M	$16M	$62M	$19M	$11M	$6M
Investing Cash Flow	$38M	$78M	$130M	$3M	$181M	$-117M	$-482M	$736.0K
Stock Issued	·	·	·	·	·	$272M	$321M	·
Net Stock Activity	·	·	·	·	·	$272M	·	·
Financing Cash Flow	$30M	$241.0K	$2M	$132M	$27M	$294M	$320M	$1M
Net Change in Cash	$22M	$-17M	$-24M	$-49M	$16M	$27M	$44M	$-30M
Free Cash Flow	$-49M	$-99M	$-167M	$-200M	$-254M	$-168M	$194M	·
Levered FCF	$-61M	·	·	·	·	·	·	·

Redditività 7

Dati annuali Redditività per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Operating Margin	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%	-155.3%	-92.2%	·
Net Margin	-21.5%	-89.1%	-132.3%	-108.0%	-134.3%	-148.6%	-80.7%	·
Pretax Margin	-21.5%	-89.2%	-132.3%	-108.1%	-134.3%	·	·	·
EBITDA Margin	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%	-155.3%	-92.2%	·
ROA	-11.3%	-26.6%	-29.7%	-22.5%	-20.3%	-14.4%	-11.0%	·
ROE	-28.2%	-62.4%	-58.3%	-37.5%	-30.8%	-23.0%	-11.9%	·
ROIC	-16.3%	·	·	·	·	·	·	·

Liquidità e Solvibilità 5

Dati annuali Liquidità e Solvibilità per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Current Ratio	3.3	2.9	4.7	5.1	3.5	6.9	7.8	·
Quick Ratio	1.3	0.9	1.2	1.2	1.4	1.3	1.4	·
Debt / Equity	0.6	0.7	0.4	·	·	·	·	·
LT Debt / Equity	0.6	0.7	0.4	·	·	·	·	·
Interest Coverage	-4.8	-14.0	-16.5	-47.2	·	·	·	·

Efficienza 3

Dati annuali Efficienza per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Asset Turnover	0.5	0.3	0.2	0.2	0.2	0.1	0.1	·
Inventory Turnover	7.8	6.3	5.2	3.4	3.0	1.9	2.6	·
Receivables Turnover	6.0	4.5	4.4	6.4	11.2	8.7	9.7	·

Per Azione 5

Dati annuali Per Azione per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Book Value / Share	$1.42	$1.37	$2.13	$3.24	$4.27	$5.40	$4.56	·
Revenue / Share	$1.83	$1.22	$1.18	$1.30	·	·	·	·
Cash Flow / Share	$-0.30	$-0.65	$-1.08	$-1.29	·	·	·	·
Cash / Share	$0.46	$0.32	$0.45	$0.63	$0.98	$0.90	$0.77	·
EPS (TTM)	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48	$-1.11	·	·

Tassi di Crescita 3

Dati annuali Tassi di Crescita per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue YoY	54.8%	5.1%	-8.1%	20.1%	56.9%	·	·	·
Revenue CAGR 3Y	14.3%	5.1%	20.1%	·	·	·	·	·
Revenue CAGR 5Y	23.0%	·	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per ADPT
Metrica	2025	2024	2023	2022	2021	2020	2019	2018
Revenue TTM	$277M	$179M	$170M	$185M	$154M	$98M	$85M	·
Net Income TTM	$-59M	$-159M	$-225M	$-200M	$-207M	$-146M	$-69M	·
Market Cap	$2.50B	$886M	$711M	$1.09B	$3.97B	$8.14B	$3.75B	·
Enterprise Value	$2.56B	$971M	$776M	·	·	·	·	·
P/E	-41.6	-5.6	-3.1	-5.5	-19.0	-53.3	·	·
P/S	9.0	5.0	4.2	5.9	25.7	82.7	44.0	·
P/B	11.4	4.4	2.3	2.4	6.6	11.0	6.6	·
P / Tangible Book	25.5	11.0	3.9	3.2	8.3	13.3	·	·
P / Cash Flow	-54.3	-9.3	-4.5	-5.9	-20.6	-54.4	18.2	·
P / FCF	-51.0	-9.0	-4.3	-5.5	-15.6	-48.3	19.3	·
EV / EBITDA	-44.8	-6.0	-3.4	·	·	·	·	·
EV / FCF	-52.3	-9.8	-4.6	·	·	·	·	·
EV / Revenue	9.2	5.4	4.6	·	·	·	·	·
Earnings Yield	-2.4%	-18.0%	-31.8%	-18.3%	-5.3%	-1.9%	·	·

Conto Economico 13

Dati trimestrali Conto Economico per ADPT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$72M	$71M	$72M	$94M	$59M	$52M	$47M	$46M	$43M	$42M	$46M	$38M	$49M	$38M	$55M	$48M
Cost of Revenue	$20M	$19M	$18M	$18M	$18M	$17M	$18M	$17M	$19M	$18M	$20M	$19M	$18M	$19M	$17M	$15M
R&D Expense	$19M	$24M	$22M	$24M	$24M	$24M	$23M	$24M	$25M	$30M	$29M	$29M	$32M	$33M	$31M	$36M
SG&A Expense	$21M	$21M	$20M	$18M	$18M	$17M	$18M	$17M	$18M	$20M	$21M	$20M	$22M	$21M	$22M	$21M
Operating Expenses	$87M	$90M	$84M	$84M	$84M	$82M	$81M	$79M	$91M	$91M	$117M	$89M	$97M	$95M	$94M	$93M
Operating Income	$-16M	$-19M	$-13M	$10M	$-25M	$-30M	$-34M	$-33M	$-47M	$-49M	$-71M	$-51M	$-48M	$-57M	$-39M	$-45M
Interest Expense	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$653.0K
Net Income	$-40M	$-20M	$-14M	$10M	$-26M	$-30M	$-34M	$-32M	$-46M	$-48M	$-69M	$-50M	$-48M	$-58M	$-40M	$-45M
EPS (Basic)	$-0.25	$-0.13	$-0.08	$0.06	$-0.17	$-0.20	$-0.22	$-0.22	$-0.31	$-0.33	$-0.48	$-0.35	$-0.33	$-0.40	$-0.27	$-0.32
EPS (Diluted)	$-0.25	$-0.13	$-0.08	$0.06	$-0.17	$-0.20	$-0.22	$-0.22	$-0.31	$-0.33	$-0.48	$-0.35	$-0.33	$-0.40	$-0.27	$-0.32
Shares (Basic)	159,855,257	155,521,048	-301,987,680	152,432,307	152,082,284	149,195,028	-293,616,372	147,516,398	147,414,095	145,787,527	-288,230,409	144,704,868	144,397,693	143,511,142	-284,473,578	142,928,654
Shares (Diluted)	159,855,257	155,521,048	-312,717,480	163,162,107	152,082,284	149,195,028	-293,616,372	147,516,398	147,414,095	145,787,527	-288,230,409	144,704,868	144,397,693	143,511,142	-284,473,578	142,928,654
EBITDA	$-16M	$-19M	·	$10M	$-25M	$-30M	·	$-33M	$-47M	$-49M	·	$-51M	$-48M	$-57M	·	$-45M

Stato Patrimoniale 27

Dati trimestrali Stato Patrimoniale per ADPT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$170M	$78M	$70M	$55M	$43M	$51M	$48M	$38M	$60M	$71M	·	$89M	$109M	$95M	·	$218M
Receivables	$50M	$48M	$50M	$45M	$44M	$44M	$42M	$41M	$36M	$42M	·	$31M	$32M	$31M	·	$27M
Inventory	$10M	$11M	$10M	$10M	$8M	$9M	$8M	$12M	$13M	$13M	·	$19M	$19M	$20M	·	$17M
Prepaid Expense	$16M	$14M	$13M	$14M	$11M	$11M	$11M	$12M	$11M	$10M	·	$13M	$9M	$10M	·	$12M
Current Assets	$421M	$292M	$300M	$281M	$262M	$256M	$284M	$308M	$352M	$374M	·	$435M	$477M	$501M	·	$564M
PP&E (Net)	$29M	$31M	$34M	$37M	$41M	$44M	$49M	$51M	$55M	$65M	·	$77M	$79M	$81M	·	$87M
PP&E (Gross)	·	·	$130M	·	·	·	$136M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$96M	·	·	·	$88M	·	·	·	·	·	·	·	·	·
Goodwill	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M	$119M	·	$119M	$119M	$119M	·	$119M
Intangibles	$884.0K	$1M	$2M	$2M	$3M	$3M	$3M	$4M	$4M	$5M	·	$6M	$6M	$6M	·	$7M
Other Non-current Assets	$1M	$1M	$1M	$2M	$2M	$2M	$2M	$3M	$3M	$3M	·	$3M	$3M	$2M	·	$2M
Total Assets	$641M	$506M	$513M	$491M	$497M	$511M	$539M	$559M	$585M	$620M	·	$718M	$765M	$791M	·	$884M
Accounts Payable	$5M	$10M	$6M	$10M	$7M	$6M	$7M	$7M	$10M	$12M	·	$4M	$9M	$6M	·	$4M
Accrued Liabilities	$11M	$7M	$8M	$7M	$7M	$8M	$8M	$6M	$7M	$8M	·	$10M	$8M	$8M	·	$11M
Current Liabilities	$88M	$87M	$90M	$83M	$92M	$88M	$98M	$88M	$88M	$83M	·	$93M	$95M	$90M	·	$104M
Capital Leases	$67M	$69M	$70M	$72M	$74M	$76M	$79M	$82M	$84M	$87M	·	$92M	$94M	$96M	·	$101M
Other Non-current Liabilities	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	$20.0K	·	·	·	·	·	·	·
Total Liabilities	$490M	$282M	$288M	$286M	$317M	$321M	$337M	$335M	$343M	$346M	·	$356M	$369M	$368M	·	$396M
Long-term Debt	$0	$131M	$131M	$132M	$134M	$134M	$133M	·	·	·	·	$130M	·	·	·	·
Total Debt	$0	$131M	·	$132M	$134M	$134M	·	$133M	$132M	$132M	·	$130M	·	·	·	·
Common Stock	$16.0K	$16.0K	$15.0K	$15.0K	$15.0K	$15.0K	$14.0K	$14.0K	$14.0K	$14.0K	·	$14.0K	$14.0K	$14.0K	·	$14.0K
Paid-in Capital	$1.57B	$1.60B	$1.58B	$1.55B	$1.54B	$1.52B	$1.51B	$1.49B	$1.48B	$1.47B	·	$1.44B	$1.42B	$1.40B	·	$1.37B
Retained Earnings	$-1.42B	$-1.38B	$-1.36B	$-1.35B	$-1.36B	$-1.33B	$-1.30B	$-1.27B	$-1.24B	$-1.19B	·	$-1.07B	$-1.02B	$-977M	·	$-879M
AOCI	$-212.0K	$-28.0K	$253.0K	$211.0K	$73.0K	$134.0K	$166.0K	$497.0K	$-182.0K	$-106.0K	·	$-250.0K	$-893.0K	$-2M	·	$-6M
Stockholders' Equity	$143M	$216M	$219M	$204M	$180M	$190M	$203M	$224M	$242M	$275M	·	$362M	$396M	$424M	·	$488M
Liabilities + Equity	$641M	$506M	$513M	$491M	$497M	$511M	$539M	$559M	$585M	$620M	·	$718M	$765M	$791M	·	$884M
Shares Outstanding	159,059,622	159,697,221	153,779,418	152,581,042	152,234,772	151,916,722	147,773,744	147,561,586	147,462,201	147,368,324	·	144,772,751	144,645,118	144,279,969	·	142,987,127

Flusso di cassa 10

Dati trimestrali Flusso di cassa per ADPT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	·	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$3M	$6M	$6M	$5M	·	·
Stock-based Comp	$11M	$12M	$13M	$13M	$13M	$12M	$13M	$14M	$13M	$14M	$16M	$15M	$17M	$15M	$14M	$14M
Amort. of Intangibles	$423.0K	$419.0K	$429.0K	$428.0K	$423.0K	$419.0K	$428.0K	$428.0K	$424.0K	$423.0K	$429.0K	$428.0K	$423.0K	$419.0K	$429.0K	$428.0K
Restructuring	·	$643.0K	·	·	·	$0	$87.0K	$193.0K	$680.0K	$1M	·	·	·	·	·	·
Operating Cash Flow	$-6M	$-10M	$2M	$-7M	$-12M	$-28M	$-12M	$-27M	$-17M	$-38M	$-27M	$-47M	$-24M	$-59M	$-30M	$-42M
CapEx	$1M	$796.0K	$636.0K	$409.0K	$655.0K	$1M	$80.0K	$344.0K	$2M	$2M	$1M	$3M	$4M	$3M	$3M	$5M
Investing Cash Flow	$-43M	$9M	$-8M	$17M	$3M	$26M	$22M	$5M	$6M	$45M	$3M	$26M	$37M	$63M	$-98M	$58M
Financing Cash Flow	$142M	$8M	$22M	$2M	$2M	$5M	$127.0K	$40.0K	$30.0K	$44.0K	$87.0K	$17.0K	$1M	$672.0K	$6.0K	$126M
Net Change in Cash	$92M	$7M	$15M	$12M	$-7M	$3M	$10M	$-22M	$-11M	$6M	$-24M	$-21M	$15M	$4M	$-128M	$141M
Free Cash Flow	·	$-10M	·	·	·	$-30M	·	·	·	$-40M	·	·	·	$-62M	·	·

Redditività 5

Dati trimestrali Redditività per ADPT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-22.0%	-27.1%	·	10.9%	-42.5%	-56.5%	·	-70.3%	-109.6%	-116.5%	·	-134.4%	-97.7%	-151.9%	·	-95.0%
Net Margin	-55.6%	-28.3%	·	10.2%	-43.5%	-56.9%	·	-69.1%	-107.0%	-113.5%	·	-132.7%	-97.7%	-153.3%	·	-94.7%
EBITDA Margin	-22.0%	-27.1%	·	10.9%	-42.5%	-56.5%	·	-70.3%	-109.6%	-116.5%	·	-134.4%	-97.7%	-151.9%	·	-95.0%
ROA	-7.0%	-3.9%	·	1.8%	-4.7%	-5.3%	·	-5.0%	-6.9%	-6.7%	·	-6.3%	-6.1%	-7.0%	·	-4.8%
ROE	-24.7%	-9.8%	·	4.5%	-12.2%	-12.8%	·	-10.9%	-14.5%	-13.6%	·	-11.8%	-10.5%	-11.8%	·	-8.0%

Liquidità e Solvibilità 5

Dati trimestrali Liquidità e Solvibilità per ADPT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	4.8	3.4	·	3.4	2.8	2.9	·	3.5	4.0	4.5	·	4.7	5.0	5.6	·	5.4
Quick Ratio	2.5	1.4	·	1.2	0.9	1.1	·	0.9	1.1	1.4	·	1.3	1.5	1.4	·	2.3
Debt / Equity	0.0	0.6	·	0.6	0.7	0.7	·	0.6	0.5	0.5	·	0.4	·	·	·	·
LT Debt / Equity	0.0	0.6	·	0.6	0.7	0.7	·	0.6	0.5	0.5	·	0.4	·	·	·	·
Interest Coverage	-5.9	-6.6	·	3.5	-8.5	-10.2	·	-11.1	-17.6	-16.3	·	-14.0	-13.3	-16.2	·	-69.6

Efficienza 3

Dati trimestrali Efficienza per ADPT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.2	0.1	0.1	·	0.1	0.1	0.1	·	0.0	0.1	0.0	·	0.1
Inventory Turnover	2.1	1.9	·	1.7	1.7	1.5	·	1.1	1.2	1.1	·	1.1	0.9	0.9	·	0.8
Receivables Turnover	1.5	1.5	·	2.2	1.5	1.2	·	1.3	1.3	1.1	·	1.3	1.8	1.4	·	2.2

Per Azione 5

Dati trimestrali Per Azione per ADPT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.90	$1.35	·	$1.34	$1.18	$1.25	·	$1.52	$1.64	$1.87	·	$2.50	$2.74	$2.94	·	$3.41
Revenue / Share	$0.45	$0.46	·	$0.58	$0.39	$0.35	·	$0.31	$0.29	$0.29	·	$0.26	$0.34	$0.26	·	$0.33
Cash Flow / Share	·	$-0.06	·	·	·	$-0.19	·	·	·	$-0.26	·	·	·	$-0.41	·	·
Cash / Share	$1.07	$0.49	·	$0.36	$0.28	$0.33	·	$0.26	$0.41	$0.48	·	$0.61	$0.76	$0.66	·	$1.52
EPS (TTM)	$-0.49	$-0.44	·	$-0.53	$-0.90	$-1.06	·	$-1.21	$-1.32	$-1.41	·	$-1.40	$-1.42	$-1.53	·	$-1.53

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per ADPT
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$295M	$276M	·	$252M	$201M	$184M	·	$169M	$172M	$166M	·	$172M	$178M	$168M	·	$170M
Net Income TTM	$-76M	$-66M	·	$-78M	$-134M	$-156M	·	$-176M	$-192M	$-203M	·	$-201M	$-203M	$-218M	·	$-216M
Market Cap	$3.41B	$2.22B	·	$2.28B	$1.77B	$1.13B	·	$756M	$534M	$473M	·	$789M	$971M	$1.27B	·	$1.02B
Enterprise Value	$3.24B	$2.27B	·	$2.36B	$1.86B	$1.21B	·	$850M	$606M	$533M	·	$830M	·	·	·	·
P/E	-43.8	-31.5	·	-28.2	-12.9	-7.0	·	-4.2	-2.7	-2.3	·	-3.9	-4.7	-5.8	·	-4.7
P/S	11.6	8.0	·	9.1	8.8	6.1	·	4.5	3.1	2.8	·	4.6	5.5	7.6	·	6.0
P/B	23.9	10.2	·	11.2	9.9	5.9	·	3.4	2.2	1.7	·	2.2	2.5	3.0	·	2.1
P / Tangible Book	148.0	23.1	·	27.4	30.5	16.5	·	7.5	4.5	3.1	·	3.3	3.6	4.3	·	2.8
P / Cash Flow	·	-232.4	·	·	·	-39.6	·	·	·	-12.3	·	·	·	-21.5	·	·
P / FCF	·	-214.5	·	·	·	-37.9	·	·	·	-11.9	·	·	·	-20.5	·	·
EV / EBITDA	-205.6	-118.2	·	229.3	-74.5	-40.9	·	-26.1	-12.8	-10.9	·	-16.3	·	·	·	·
EV / FCF	·	-219.6	·	·	·	-40.7	·	·	·	-13.4	·	·	·	·	·	·
EV / Revenue	11.0	8.2	·	9.4	9.3	6.6	·	5.0	3.5	3.2	·	4.8	·	·	·	·
Earnings Yield	-2.3%	-3.2%	·	-3.5%	-7.7%	-14.3%	·	-23.6%	-36.5%	-43.9%	·	-25.7%	-21.2%	-17.3%	·	-21.5%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$277M	$179M	$170M	$185M	$154M
Margine Operativo %	-20.6%	-90.8%	-133.3%	-108.0%	-135.4%
Utile netto	$-59M	$-159M	$-225M	$-200M	$-207M
EPS Diluito	$-0.39	$-1.08	$-1.56	$-1.40	$-1.48

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.6	0.7	0.4	—	—
Rapporto corrente	3.3	2.9	4.7	5.1	3.5
Quick Ratio	1.3	0.9	1.2	1.2	1.4

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-49M	$-99M	$-167M	$-200M	$-254M

Ultime notizie Notizie recenti che menzionano questa società

Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026 Yahoo Finance · 2 mesi, 2 settimane fa
Il Chief Operating Officer di Adaptive Biotechnologies ha venduto oltre 19.000 azioni della società. Ecco cosa significa per gli investitori. Nasdaq · 3 mesi, 2 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 316 filer · $2.4B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
55 (+6 vs trimestre precedente)	37 (0 vs trimestre precedente)	108 (+13 vs trimestre precedente)	79 (-18 vs trimestre precedente)	+20.1M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
VIKING GLOBAL INVESTORS LP	$643.365.037	29.993.708	26,70%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$137.356.941	6.403.587	5,70%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$117.465.155	5.476.231	4,88%	Azioni
WESTFIELD CAPITAL MANAGEMENT CO LP	$91.540.985	4.267.645	3,80%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$75.636.776	3.526.190	3,14%	Azioni
STATE STREET CORP	$74.181.636	3.458.388	3,08%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$67.416.242	3.142.305	2,80%	Azioni
UBS Group AG	$61.392.474	2.862.120	2,55%	Opzione Call
Driehaus Capital Management LLC	$54.219.229	2.527.703	2,25%	Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$54.153.099	2.524.620	2,25%	Azioni
FRED ALGER MANAGEMENT, LLC	$44.879.492	2.092.284	1,86%	Azioni
ARK Investment Management LLC	$44.837.058	2.090.306	1,86%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$42.284.385	1.971.300	1,76%	Opzione Call
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$40.523.000	1.889.188	1,68%	Azioni
TORONTO DOMINION BANK	$38.610.000	1.800.000	1,60%	Opzione Call
Aristotle Atlantic Partners, LLC	$31.871.697	1.485.860	1,32%	Azioni
Sumitomo Mitsui Trust Group, Inc.	$28.525.411	1.329.856	1,18%	Azioni
Amova Asset Management Americas, Inc.	$28.512.113	1.329.856	1,18%	Azioni
OBERWEIS ASSET MANAGEMENT INC/	$27.000.209	1.258.751	1,12%	Azioni
PERCEPTIVE ADVISORS LLC	$26.111.621	1.217.325	1,08%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$25.279.940	1.178.552	1,05%	Azioni
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$22.993.006	1.071.935	0,95%	Azioni
AMERIPRISE FINANCIAL INC	$21.973.304	1.024.394	0,91%	Azioni
Blue Water Life Science Advisors, LP	$21.667.610	1.010.145	0,90%	Azioni
VANGUARD FIDUCIARY TRUST CO	$20.049.508	934.709	0,83%	Azioni
Aberdeen Group plc	$19.712.507	918.998	0,82%	Azioni
Freestone Grove Partners LP	$18.912.208	881.688	0,78%	Azioni
KENNEDY CAPITAL MANAGEMENT LLC	$18.228.103	849.795	0,76%	Azioni
PANAGORA ASSET MANAGEMENT INC	$16.679.842	777.615	0,69%	Azioni
Granite Investment Partners, LLC	$16.242.305	757.217	0,67%	Azioni
Connor, Clark & Lunn Investment Management Ltd.	$16.124.115	751.707	0,67%	Azioni
Trexquant Investment LP	$15.792.777	736.260	0,66%	Azioni
FMR LLC	$15.183.726	707.866	0,63%	Azioni
BANK OF AMERICA CORP /DE/	$14.875.790	693.510	0,62%	Azioni
Hillsdale Investment Management Inc.	$14.676.454	684.217	0,61%	Azioni
GOLDMAN SACHS GROUP INC	$13.224.526	616.528	0,55%	Azioni
NEXT CENTURY GROWTH INVESTORS LLC	$13.080.853	609.830	0,54%	Azioni
TUDOR INVESTMENT CORP ET AL	$11.657.753	543.485	0,48%	Azioni
JENNISON ASSOCIATES LLC	$11.594.647	540.543	0,48%	Azioni
ExodusPoint Capital Management, LP	$11.114.232	518.146	0,46%	Azioni
MILLENNIUM MANAGEMENT LLC	$10.830.298	504.909	0,45%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$10.734.760	500.455	0,45%	Azioni
Parkman Healthcare Partners LLC	$10.445.807	486.984	0,43%	Azioni
Qube Research & Technologies Ltd	$10.290.251	479.732	0,43%	Azioni
ESSEX INVESTMENT MANAGEMENT CO LLC	$10.140.766	472.763	0,42%	Azioni
JANE STREET GROUP, LLC	$10.010.608	466.695	0,42%	Azioni
D. E. Shaw & Co., Inc.	$9.608.034	447.927	0,40%	Azioni
FIRST TRUST ADVISORS LP	$8.962.303	417.823	0,37%	Azioni
PEREGRINE CAPITAL MANAGEMENT LLC	$8.431.888	393.095	0,35%	Azioni
1492 Capital Management LLC	$8.211.918	382.840	0,34%	Azioni
VICTORY CAPITAL MANAGEMENT INC	$8.177.770	381.248	0,34%	Azioni
AQR CAPITAL MANAGEMENT LLC	$7.578.735	353.321	0,31%	Azioni
BlackRock, Inc.	$7.573.673	353.085	0,31%	Azioni
AFFINITY WEALTH MANAGEMENT LLC	$7.348.105	342.569	0,30%	Azioni
Lisanti Capital Growth, LLC	$6.974.575	325.155	0,29%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$6.495.060	302.800	0,27%	Azioni
MARSHALL WACE, LLP	$6.265.095	292.079	0,26%	Azioni
Polar Asset Management Partners Inc.	$5.846.648	272.571	0,24%	Azioni
Allianz Asset Management GmbH	$5.271.693	379.805	0,22%	Azioni
Swiss National Bank	$4.969.965	231.700	0,21%	Azioni
Susquehanna Portfolio Strategies, LLC	$4.700.789	219.151	0,20%	Azioni
Cubist Systematic Strategies, LLC	$4.339.724	290.088	0,18%	Azioni
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.	$4.334.983	202.097	0,18%	Azioni
RHUMBLINE ADVISERS	$4.275.746	199.336	0,18%	Azioni
SUSQUEHANNA ADVISORS GROUP, INC.	$3.951.090	184.200	0,16%	Azioni
ARISTEIA CAPITAL, L.L.C.	$3.936.075	183.500	0,16%	Azioni
CITADEL ADVISORS LLC	$3.890.086	181.356	0,16%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$3.562.437	166.081	0,15%	Azioni
NEW YORK STATE COMMON RETIREMENT FUND	$3.130.542	145.946	0,13%	Azioni
BLAIR WILLIAM & CO/IL	$3.004.308	140.061	0,12%	Azioni
PRUDENTIAL FINANCIAL INC	$2.987.985	139.300	0,12%	Azioni
Bank of New York Mellon Corp	$2.936.162	136.884	0,12%	Azioni
Y-Intercept (Hong Kong) Ltd	$2.898.689	135.137	0,12%	Azioni
OSAIC HOLDINGS, INC.	$2.896.766	135.053	0,12%	Azioni
ALGERT GLOBAL LLC	$2.827.753	131.830	0,12%	Azioni
LPL Financial LLC	$2.730.842	127.312	0,11%	Azioni
EP Wealth Advisors, LLC	$2.669.474	124.451	0,11%	Azioni
Ensign Peak Advisors, Inc	$2.590.517	120.770	0,11%	Azioni
Nuveen, LLC	$2.520.868	117.523	0,10%	Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$2.503.687	116.722	0,10%	Azioni
XTX Topco Ltd	$2.424.772	113.043	0,10%	Azioni
ALLIANCEBERNSTEIN L.P.	$2.384.973	171.828	0,10%	Azioni
NEUBERGER BERMAN GROUP LLC	$2.328.934	108.575	0,10%	Azioni
Freestone Capital Holdings, LLC	$2.225.502	103.753	0,09%	Azioni
Squarepoint Ops LLC	$2.207.141	102.897	0,09%	Azioni
POLEN CAPITAL MANAGEMENT LLC	$2.197.703	102.457	0,09%	Azioni
MORGAN STANLEY	$2.121.202	98.890	0,09%	Azioni
Robertson Stephens Wealth Management, LLC	$2.085.326	97.218	0,09%	Azioni
Universal- Beteiligungs- und Servicegesellschaft mbH	$2.081.658	97.047	0,09%	Azioni
TWO SIGMA ADVISERS, LP	$2.080.344	128.100	0,09%	Azioni
CITIGROUP INC	$2.043.799	95.282	0,08%	Azioni
Huntleigh Advisors, Inc.	$1.998.523	93.171	0,08%	Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$1.993.973	143.658	0,08%	Azioni
Edge Wealth Management LLC	$1.930.500	90.000	0,08%	Azioni
MetLife Investment Management, LLC	$1.924.944	89.741	0,08%	Azioni
Bellevue Group AG	$1.918.467	89.439	0,08%	Azioni
CAPITAL FUND MANAGEMENT S.A.	$1.824.579	85.062	0,08%	Azioni
TD Asset Management Inc	$1.762.890	82.186	0,07%	Azioni
ENVESTNET ASSET MANAGEMENT INC	$1.683.889	78.503	0,07%	Azioni
VANGUARD ASSET MANAGEMENT, Ltd	$1.663.683	77.561	0,07%	Azioni

Insider aziendali 27 insider · 16 dirigenti · 8 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Chad M Robins	CEO and Chairman	06 Marzo 2025 S	2.959.249	0	$0
Kyle Piskel	Chief Financial Officer	16 Maggio 2025 S	269.581	0	$0
Tycho Peterson	Chief Financial Officer	05 Marzo 2024 S	531.553	0	$0
Chad M Cohen	Chief Financial Officer	22 Dicembre 2021 M	21.604	0	$0
Julie Rubinstein	President and COO	05 Marzo 2025 S	588.249	0	$0
Mark R Adams	Chief Operating Officer	11 Aprile 2023 S	175.361	0	$0
Harlan S Robins	Chief Scientific Officer	21 Luglio 2026 M	812.058	6	$-21.129.500
Francis Lo	Chief People Officer	15 Luglio 2026 M	230.713	5	$-5.241.916
Sharon Benzeno	Chief Commercial Ofc Imm Med	29 Giugno 2026 M	221.278	2	$-3.503.510
Stacy L Taylor	SVP and General Counsel	22 Agosto 2024 S	139.365	0	$0
Nitin Sood	Chief Commercial Officer, MRD	08 Agosto 2023 S	214.808	0	$0
Lance Baldo	Chief Medical Officer	08 Marzo 2022 S	17.171	0	$0
Jyoti Palaniappan	SVP, Diagnostics, T-Detect	19 Luglio 2021 M	9.158	0	$0
Henning Thorsen	SVP, Commercial Operations	17 Maggio 2021 A	29.061	0	$0
Nancy Louise Hill	EVP, Operations & Program Mana	19 Gennaio 2021 M	10.000	0	$0
Charles Sang	SVP, External Affairs	11 Dicembre 2020 M	0	0	$0
Michelle Renee Griffin	Direttore	25 Giugno 2026 M	15.625	3	$-2.000.259
Katey Einterz Owen	Direttore	04 Marzo 2025 A	72.629	0	$0
Michael J Pellini	Direttore	04 Marzo 2025 A	69.690	0	$0
Kevin T Conroy	Direttore	06 Marzo 2023 A	22.968	0	$0
Leslie Trigg	Direttore	06 Marzo 2023 A	25.907	0	$0
David E. Goel	Direttore	15 Febbraio 2021 A	1.504	0	$0
Andris A Zoltners	Direttore	13 Febbraio 2020 A	3.621.016	0	$0
Susan Bobulsky	—	10 Agosto 2026 S	396.989	7	$-627.390
Robert Hershberg	—	04 Marzo 2026 A	62.347	1	$-367.488
Peter M Neupert	—	04 Marzo 2026 A	240.315	0	$0
Eric Dobmeier	—	14 Febbraio 2021 A	1.504	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 48 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
ARKG · ARK ETF Trust	2,42%	2.123.561 NS	30 Aprile 2026	N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST	1,74%	65.865 NS	30 Aprile 2026	N-PORT
MEDI · Harbor ETF Trust	1,06%	20.675 NS	30 Aprile 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	0,76%	137.018 SH	08 Agosto 2026	Giornaliero
FYC · First Trust Exchange-Traded AlphaDE…	0,33%	247.631 NS	30 Aprile 2026	N-PORT
IBB · iShares Trust	0,28%	1.135.939 SH	08 Agosto 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,27%	8.711 SH	08 Agosto 2026	Giornaliero
IWO · iShares Trust	0,22%	1.394.571 SH	08 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,19%	165.252 SH	08 Agosto 2026	Giornaliero
AFSM · First Trust Exchange-Traded Fund VI…	0,16%	10.411 NS	31 Maggio 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,15%	74.955 NS	31 Maggio 2026	N-PORT
ESSC · Strategy Shares	0,15%	2.670 NS	30 Aprile 2026	N-PORT
BIB · ProShares Trust	0,12%	5.692 NS	31 Maggio 2026	N-PORT
FYX · First Trust Exchange-Traded AlphaDE…	0,12%	99.767 NS	30 Aprile 2026	N-PORT
ISCG · iShares Trust	0,11%	48.637 SH	08 Agosto 2026	Giornaliero
IWM · iShares Trust	0,11%	3.898.560 SH	08 Agosto 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,10%	886.884 SH	08 Agosto 2026	Giornaliero
SMLF · iShares Trust	0,09%	170.751 SH	08 Agosto 2026	Giornaliero
GSSC · Goldman Sachs ETF Trust	0,09%	59.120 NS	31 Maggio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,09%	99.762 SH	08 Agosto 2026	Giornaliero
ESML · iShares Trust	0,08%	103.428 SH	08 Agosto 2026	Giornaliero
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,08%	38.966 NS	30 Aprile 2026	N-PORT
GINN · Goldman Sachs ETF Trust	0,07%	9.805 NS	31 Maggio 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,07%	23.092 NS	30 Aprile 2026	N-PORT
RSSL · Global X Funds	0,06%	64.737 NS	30 Aprile 2026	N-PORT
VFMO · VANGUARD WELLINGTON FUND	0,06%	51.690 SH	08 Agosto 2026	Giornaliero
ITWO · ProShares Trust	0,06%	7.032 NS	31 Maggio 2026	N-PORT
ISCB · iShares Trust	0,06%	6.849 SH	08 Agosto 2026	Giornaliero
VBK · VANGUARD INDEX FUNDS	0,04%	1.011.327 SH	08 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,04%	345.932 SH	08 Agosto 2026	Giornaliero
SCHA · SCHWAB STRATEGIC TRUST	0,04%	572.294 NS	31 Maggio 2026	N-PORT
UWM · ProShares Trust	0,03%	5.500 NS	31 Maggio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,03%	1.415.247 SH	08 Agosto 2026	Giornaliero
WSML · iShares Trust	0,03%	7.505 SH	08 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,03%	52.346 NS	30 Aprile 2026	N-PORT
URTY · ProShares Trust	0,02%	5.565 NS	31 Maggio 2026	N-PORT
VB · VANGUARD INDEX FUNDS	0,02%	1.746.783 SH	08 Agosto 2026	Giornaliero
OMFS · Invesco Exchange-Traded Self-Indexe…	0,01%	1.203 SH	08 Agosto 2026	Giornaliero
HDG · ProShares Trust	0,01%	140 NS	31 Maggio 2026	N-PORT
TILT · FlexShares Trust	0,01%	9.089 NS	30 Aprile 2026	N-PORT
ONEQ · Fidelity Commonwealth Trust	0,01%	42.372 NS	31 Maggio 2026	N-PORT
IWV · iShares Trust	0,01%	43.269 SH	08 Agosto 2026	Giornaliero
ITOT · iShares Trust	0,00%	170.705 SH	08 Agosto 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,00%	28.496 NS	30 Aprile 2026	N-PORT
SCHB · SCHWAB STRATEGIC TRUST	0,00%	75.853 NS	31 Maggio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	4.835.465 SH	08 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	12.307 SH	08 Agosto 2026	Giornaliero
AVSU · AMERICAN CENTURY ETF TRUST	0,00%	15 NS	31 Maggio 2026	N-PORT

Informazioni su Adaptive Biotechnologies Corporation - Common Stock Panoramica della società da Wikipedia

ADPT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

ADPT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

ADPT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 316 filer · $2.4B totale · Aggiornato al 30 Giugno 2026

Insider aziendali 27 insider · 16 dirigenti · 8 direttori

Proprietà ETF Posseduti da 48 ETF